Investing in Biotech has Never Been Easier

discount

BioPortfolio is the only biotech investment newsletter that offers its full history to every subscriber. Unlike other services that hype specific success stories with each newsletter, we show exactly how much you would have made investing according to the sentiment-based model – not just specific biotech stock picks. We use advanced natural language processing algorithms to pick up millions of analyst and blogger opinions in real-time to identify the best trading opportunities. Each week we send our subscribers the three best biotech stocks trades – two long, one short – that the system identifies (view example).

See Plans & Pricing > Save up to 25% Now
x

BioPortfolio - April 02, 2019
Your weekly BioPortfolio report brought to you by SmarterAnalyst
You can download the full history of the new archive by clicking here.

Weekly Update
Last week was a positive week for the IBB moving 3.79%. BioPortfolio under-performed the index by -0.34% with a total return of 3.45%. RGEN (long) and RGNX (long) had returns of 4.19% and 6.5% respectively, IBB (Short) had a return of -3.79%. Return is measured from Monday's opening price to last Friday’s closing price based on our default allocation model.
Last Weeks
Performance


IBB
3.79%

BioPortlio
3.45%
Portfolio Quick View
Repligen (RGEN)
The first long pick Repligen Corp is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies. It also supplies growth factor products.
RegenXBio Inc. (RGNX)
The second long pick REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
iShares Nasdaq Biotechnology (IBB)
The short pick , the iShares Nasdaq Biotechnology fund is an investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc.
Analysis & Research

Using TipRanks' algorithms we are able to search the web for all relevant information about each pick. Below we provide blogger, analyst, news, and insider coverage for any activity on RGEN, RGNX and IBB in the last 30 days.

Long: Repligen (RGEN)

High Quality Blogger Coverage

Long: RegenXBio Inc. (RGNX)

High Quality Blogger Coverage Recent Analysts Ratings
  • Analyst Reni of Raymond James reccomends buying RGNX with a 1 year price target of $94.00
News Worth Mentioning
  • Yahoo Finance: REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists (open)
  • Site NA: Regenxbio (RGNX) stock upgraded to strong buy (open)
Insider Transactions
  • Insider Vasista Vittal bought shares valued at $102000.00 on 2/11/2019
  • Insider Simpson Curran sold shares valued at $2195106.56 on 2/7/2019
  • Insider Mills Kenneth T. bought shares valued at $38250.00 on 2/5/2019

Short: iShares Nasdaq Biotechnology (IBB)

General Information
General Information

Data provider: TipRanks.com
Investment horizon: weekly
Universe: US Biotech Sector

The audited historical performance of this strategy and information regarding allocation and strategy can be found on the official Smarter Analyst page for BioPortfolio.
License Information
Member: *|FNAME|* *|LNAME|*
Contract: *|TYPE|*
License #: *|ID|* 

*No portion of the above message and file may be republished, re-transmitted or forwarded without express written consent from SmarterAnalyst.com 
Questions? Contact us at premium@smarteranalyst.com
Disclaimer: The advice provided on this newsletter is SmarterAnalyst's general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. If any products are detailed on this website, you should obtain a Product Disclosure Statement relating to the products and consider its contents before making any decisions. Where quoted, past performance is not indicative of future performance. SmarterAnalyst disclaims all and any guarantees, undertakings and warranties, expressed or implied, and shall not be liable for any loss or damage whatsoever (including human or computer error, negligent or otherwise, or incidental or consequential loss or damage) arising out of or in connection with any use or reliance on the information or advice on this newsletter. The user must accept sole responsibility associated with the use of the material on this newsletter, irrespective of the purpose for which such use or results are applied. The information on this newsletter is no substitute for financial advice.

Important: The links below are in compliance with international spam law; however, removing yourself from the newsletter's mailing list does not cancel the service! For any inquiries regarding upgrades/cancellations or billing please contact us directly at premium@smarteranalyst.com
As featured on

Few investments provide as much explosive returns as biotech stocks. However, mistimed investments in this arena are doomed to failure. The solution is our Bio Portfolio. That is because we use advanced algorithms to scan the activity of expert investors to find when the time is right to enjoy upside price action. The impressive alpha of this strategy has been on continual display since inception as you will see in the performance details. Perhaps its time you add some of this biotech upside potential to your portfolio.

Sign up to receive:

  • Two long & one short biotech stock picks sent each Monday at 8 AM EST

  • Detailed research behind each pick, including recent analyst, blogger news & insider coverage.

  • Personal email support from our analysts for all questions regarding the service and strategy

  • Best Year: 2012 110.5%
  • Average Annual Return +69.9%
  • Advantage Over Benchmark 639.7%

  • alt text Weekly Newsletter
  • Bio Investors
  • Picks Per Week
  • High Volatility

About BioPortfolio

Biotech stocks are notoriously volatile as they react quickly and significantly to investor expectations. At BioPortfolio, we generate alpha by pinpointing exactly where that expectation is. Deploying TipRanks’ award-winning algorithm, we highlight the coming week’s best biotech stock picks by gathering the most extensive data available on the universe of biotech stocks. Once a particular stock exceeds its average publicity threshold, it will trigger a signal.

For example, Gilead Sciences, Inc. (NASDAQ: GILD) is a very well-covered stock, mentioned in hundreds of articles on a daily basis. It would take a very strong positive or negative sentiment to produce enough material for our system to detect it as having a positive or negative outlook. However, when a less-covered biotech stock suddenly begins to receive a lot of positive coverage, it will trigger our system. Out of all the stocks that are triggered by these signals, the two with the most bullish sentiments and one with the most bearish sentiment will be featured on the BioPortfolio newsletter.

https://smarteranalyst.staging.wpengine.com/wp-content/uploads/2017/08/tipranksapi.png

Our measuring assumes you are 100% invested, with the value split evenly between our top two picks (50%/50%). A further 50% leveraged investment is allocated to our short pick, ensuring some level of market neutrality to the overall sector risk. Since the beginning of 2011, BioPortfolio has generated nearly 1,000% in compounding returns and is still going strong.

The newsletter is sent every Monday morning at 9AM EST, giving you plenty of time to evaluate the weekly picks before the market opens. BioPortfolio is simple to maintain because most picks only require rebalancing every 3-4 weeks, making it suitable for both beginner and veteran investors. Due to the very large swings, we highly recommend making BioPortfolio a portion of your overall investment strategy. Potential picks

Reviews

Read what our customers are saying about their experience
with Smarter Trades Collection

  • Great Timing

    "Great on timing the buys and sells around large swings. To me this is the only way to profit from this sector long term"

    Greg M.

  • No Gimmicks

    "Very consistent investment newsletter, better than anything else I have ever used. It's very clear and insightful with no gimmicks."

    Garret L.

  • Helped Me Relax

    "I kept on mistiming my Biotech trades, this tool really helped me take the human anxiety factor out of the equation. Thanks!."

    Ann B.

  • 40% in a Month!

    "I only used your short picks (although fairly recently), made over 40% in a month!"

    Peter G.

  • Would Love More Picks!

    "Thanks for this great strategy. I like the simple stock pick approach without the long auto generated filler texts. Would love to have even more picks based on your algorithm each week to increase my diversification"

    Danny P.

Support

All the Support You Need to Maximize Your Trading Success

How do I receive the weekly picks?

The two long picks and one short pick are sent every Monday by 9 AM EST to the email you provide us upon signing up.

On what data is the model based?

The model is based on real time data collected from the internet by the financial accountability engine TipRanks. This includes what analysts and bloggers are saying on over 100 covered sites.

Can I contact you for questions?

Yes, the strategy has a personal support email address for its subscribers. An analyst specializing in the model can answer all questions regarding the service and strategy.

What does “risk free” mean?

All audited newsletters are protected by a SmarterAnalyst’s cancel anytime guarantee. If you wish to discontinue the service simply email premium@smarteranalyst.com and you will have your auto-renewal cancelled immediately, no questions asked. Please see our terms & conditions to learn more about our commitment and user protection policy.

Is this strategy suitable for beginners as well?

Yes. This strategy is very easy to implement and is suitable for beginners as well. Please note that biotech stocks are very volatile and with a short position you can lose more than you initial invested money.

Can I change my plan later?

Yes, you can upgrade anytime by contacting our support team.

  • 100% No-Risk Guarantee

    If you are not fully satisfied, request to cancel within 30 days of your purchase and receive a full refund.

  • 24/7 Customer Support

    We are here to make sure that you get the most out of the Smarter Trades Collection to maximize your trading success

See Plans & Pricing > Save up to 25% Now

Want to get more? Bio Portfolio is just 1 out of 6 data driven Investment Newsletters. Get them for 80% off

Outperform the market with Smarter Analyst powered investment newsletters


Smarter Trades Collection

6 Proven Strategies are Better Than 1… Especially at a Great Discount

Here you will find a well rounded set of proven strategies where each investor selects the trades that best suits their unique investing style. In total this collection includes 6 services providing timely recommendations ranging from small cap growth stocks to emerging biotech picks to hot insider trades. The performance of each strategy is sure to impress. Proven performance + More trading ideas + 80% discount

I want it All >

As featured on:

  • CNBC
  • Reuters
  • FOX Business
  • Barron's
  • The New Web
  • The New York Times

A multi-award winning platform

  • KPMG

    KPMG

    2016 Fintech

    Top 100 Leading
    Global Innovators

    KPMG
  • Finovate

    Finovate

    Best of Show Award

    Finovate Fall 2013
    Finovate Spring 2013

    Finovate
  • IBM Watson

    IBM Watson

    2015 IBM Watson

    First Place for Outstanding Achievement

    IBM Watson